239 related articles for article (PubMed ID: 19223331)
41. Functional compatibility between isoform alpha and beta of type II DNA topoisomerase.
Sakaguchi A; Kikuchi A
J Cell Sci; 2004 Mar; 117(Pt 7):1047-54. PubMed ID: 14996935
[TBL] [Abstract][Full Text] [Related]
42. Role of an inverted CCAAT element in human topoisomerase IIalpha gene expression in ICRF-187-sensitive and -resistant CEM leukemic cells.
Morgan SE; Beck WT
Mol Pharmacol; 2001 Feb; 59(2):203-11. PubMed ID: 11160854
[TBL] [Abstract][Full Text] [Related]
43. DNA-binding activity of rat DNA topoisomerase II α C-terminal domain contributes to efficient DNA catenation in vitro.
Kawano S; Kato Y; Okada N; Sano K; Tsutsui K; Tsutsui KM; Ikeda S
J Biochem; 2016 Mar; 159(3):363-9. PubMed ID: 26527691
[TBL] [Abstract][Full Text] [Related]
44. p53 regulates the minimal promoter of the human topoisomerase IIalpha gene.
Sandri MI; Isaacs RJ; Ongkeko WM; Harris AL; Hickson ID; Broggini M; Vikhanskaya F
Nucleic Acids Res; 1996 Nov; 24(22):4464-70. PubMed ID: 8948636
[TBL] [Abstract][Full Text] [Related]
45. Phosphorylation and stabilization of topoisomerase IIα protein by p38γ mitogen-activated protein kinase sensitize breast cancer cells to its poisons.
Qi X; Hou S; Lepp A; Li R; Basir Z; Lou Z; Chen G
J Biol Chem; 2011 Oct; 286(41):35883-35890. PubMed ID: 21878638
[TBL] [Abstract][Full Text] [Related]
46. Gene regulation and priming by topoisomerase IIα in embryonic stem cells.
Thakurela S; Garding A; Jung J; Schübeler D; Burger L; Tiwari VK
Nat Commun; 2013; 4():2478. PubMed ID: 24072229
[TBL] [Abstract][Full Text] [Related]
47. Down-regulation of human topoisomerase IIalpha expression correlates with relative amounts of specificity factors Sp1 and Sp3 bound at proximal and distal promoter regions.
Williams AO; Isaacs RJ; Stowell KM
BMC Mol Biol; 2007 May; 8():36. PubMed ID: 17511886
[TBL] [Abstract][Full Text] [Related]
48. Comparison of topoisomerase-IIalpha gene status between primary breast cancer and corresponding distant metastatic sites.
Durbecq V; Di Leo A; Cardoso F; Rouas G; Leroy JY; Piccart M; Larsimont D
Breast Cancer Res Treat; 2003 Feb; 77(3):199-204. PubMed ID: 12602919
[TBL] [Abstract][Full Text] [Related]
49. Two differentially spliced forms of topoisomerase IIalpha and beta mRNAs are conserved between birds and humans.
Petruti-Mot AS; Earnshaw WC
Gene; 2000 Nov; 258(1-2):183-92. PubMed ID: 11111056
[TBL] [Abstract][Full Text] [Related]
50. Interaction between glucose-regulated destruction domain of DNA topoisomerase IIalpha and MPN domain of Jab1/CSN5.
Yun J; Tomida A; Andoh T; Tsuruo T
J Biol Chem; 2004 Jul; 279(30):31296-303. PubMed ID: 15126503
[TBL] [Abstract][Full Text] [Related]
51. Topoisomerase IIalpha expression in acute myeloid leukaemia cells that survive after exposure to daunorubicin or ara-C.
Tina E; Prenkert M; Höglund M; Paul C; Tidefelt U
Oncol Rep; 2009 Dec; 22(6):1527-31. PubMed ID: 19885609
[TBL] [Abstract][Full Text] [Related]
52. Inhibition of DNA topoisomerase II alpha gene expression by the p53 tumor suppressor.
Wang Q; Zambetti GP; Suttle DP
Mol Cell Biol; 1997 Jan; 17(1):389-97. PubMed ID: 8972219
[TBL] [Abstract][Full Text] [Related]
53. Glucose-regulated stresses cause degradation of DNA topoisomerase IIalpha by inducing nuclear proteasome during G1 cell cycle arrest in cancer cells.
Kim HD; Tomida A; Ogiso Y; Tsuruo T
J Cell Physiol; 1999 Jul; 180(1):97-104. PubMed ID: 10362022
[TBL] [Abstract][Full Text] [Related]
54. The α isoform of topoisomerase II is required for hypercompaction of mitotic chromosomes in human cells.
Farr CJ; Antoniou-Kourounioti M; Mimmack ML; Volkov A; Porter AC
Nucleic Acids Res; 2014 Apr; 42(7):4414-26. PubMed ID: 24476913
[TBL] [Abstract][Full Text] [Related]
55. Substrate specificity plays an important role in uncoupling the catalytic and scaffolding activities of rat testis DNA topoisomerase IIalpha.
Bakshi R; Galande S; Muniyappa K
J Biomol Struct Dyn; 2001 Apr; 18(5):749-60. PubMed ID: 11334111
[TBL] [Abstract][Full Text] [Related]
56. The association between the p53/topoisomerase I and p53/ topoisomerase IIalpha immunophenotypes and the progression of ovarian carcinomas.
Bar JK; Grelewski P; Noga L; Rabczyński J; Gryboś M; Jeleń M
Adv Clin Exp Med; 2012; 21(1):35-42. PubMed ID: 23214297
[TBL] [Abstract][Full Text] [Related]
57. Association of human DNA topoisomerase IIalpha with mitotic chromosomes in mammalian cells is independent of its catalytic activity.
Mo YY; Beck WT
Exp Cell Res; 1999 Oct; 252(1):50-62. PubMed ID: 10502399
[TBL] [Abstract][Full Text] [Related]
58. Chiral discrimination and writhe-dependent relaxation mechanism of human topoisomerase IIα.
Seol Y; Gentry AC; Osheroff N; Neuman KC
J Biol Chem; 2013 May; 288(19):13695-703. PubMed ID: 23508957
[TBL] [Abstract][Full Text] [Related]
59. The dynamics of DNA topoisomerase IIalpha in living cells.
Daum JR; Mo YY; Gorbsky GJ
Methods Mol Biol; 2009; 582():233-44. PubMed ID: 19763954
[TBL] [Abstract][Full Text] [Related]
60. Topoisomerase IIalpha gene expression is regulated by the p53 tumor suppressor gene in nonsmall cell lung carcinoma patients.
Liu D; Huang CL; Kameyama K; Hayashi E; Yamauchi A; Sumitomo S; Yokomise H
Cancer; 2002 Apr; 94(8):2239-47. PubMed ID: 12001123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
